[HTML][HTML] Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN …
Background Merkel cell carcinoma (MCC) is a rare, aggressive skin cancer associated with
a high risk of metastasis. In 2017, avelumab (anti–programmed death-ligand 1 (PD-L1)) …
a high risk of metastasis. In 2017, avelumab (anti–programmed death-ligand 1 (PD-L1)) …
[HTML][HTML] First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II …
Background Avelumab (anti-programmed death ligand 1 (PD-L1)) is approved in multiple
countries for the treatment of metastatic Merkel cell carcinoma (mMCC), a rare and …
countries for the treatment of metastatic Merkel cell carcinoma (mMCC), a rare and …
[HTML][HTML] 604 First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from the JAVELIN Merkel 200 trial
Background Prior to the approval of immune checkpoint inhibitors, patients with metastatic
Merkel cell carcinoma (mMCC), a rare and aggressive neuroendocrine skin carcinoma, had …
Merkel cell carcinoma (mMCC), a rare and aggressive neuroendocrine skin carcinoma, had …
[HTML][HTML] Patient experiences with avelumab in treatment-Naïve metastatic Merkel cell carcinoma: longitudinal qualitative interview findings from JAVELIN Merkel 200 …
J Lambert, A Marrel, SP D'Angelo, MA Burgess… - The Patient-Patient …, 2020 - Springer
Abstract Background and Objective Avelumab is approved for the treatment of metastatic
Merkel cell carcinoma, a rare aggressive skin cancer with a poor prognosis. The aim of this …
Merkel cell carcinoma, a rare aggressive skin cancer with a poor prognosis. The aim of this …
Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab
Aim: To evaluate changes in health-related quality of life (HRQoL) in a Phase II trial
(NCT02155647) of treatment-naive patients with metastatic Merkel cell carcinoma treated …
(NCT02155647) of treatment-naive patients with metastatic Merkel cell carcinoma treated …
[HTML][HTML] Evaluation of the potential for QTc prolongation with avelumab
Y Vugmeyster, G Güzel, M Hennessy, AH Loos… - Cancer Chemotherapy …, 2019 - Springer
Purpose To report integrated electrocardiogram (ECG) summary and exposure–QTc
analyses for avelumab, a human immunoglobulin G1 monoclonal antibody that binds …
analyses for avelumab, a human immunoglobulin G1 monoclonal antibody that binds …
Expressionsanalyse humaner Fibrochondrozyten in Zellkultur
G Güzel - 2009 - tobias-lib.ub.uni-tuebingen.de
Viele Erkrankungen des Kniegelenks lassen sich auf eine degenerative oder traumatische
Läsion des Meniskus zurückführen. Der Meniskus spielt dabei eine entscheidende Rolle für …
Läsion des Meniskus zurückführen. Der Meniskus spielt dabei eine entscheidende Rolle für …